Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label Phase I/II Study of XZP-3287 in Metastasis Solid Tumors in China

NCT04539496 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.

NCT NCT04539496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label Phase I/II Study of XZP-3287 in Metastasis Solid Tumors in China
Lead sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 22, 2018
Completion date
December 31, 2025
Enrollment
402 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, metastasis solid tumors